Page last updated: 2024-10-28

glipizide and Liver Neoplasms

glipizide has been researched along with Liver Neoplasms in 2 studies

Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.

Liver Neoplasms: Tumors or cancer of the LIVER.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qi, C1
Yang, Y2
Li, J2
Zhou, Q1
Wen, Y1
Zeng, C1
Zheng, L1
Zhang, Q1
He, X1
Zhou, J1
Shao, C1
Wang, L1
Ahrén, B1
Scherstén, B1

Other Studies

2 other studies available for glipizide and Liver Neoplasms

ArticleYear
Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis.
    Scientific reports, 2016, 06-13, Volume: 6

    Topics: Angiogenesis Inhibitors; Animals; Antigens, Polyomavirus Transforming; Cell Line, Tumor; Cell Prolif

2016
Effect of sulfonylurea on glucose, insulin and C-peptide responses to a meal stimulus in a patient with type 2 diabetes and liver disease.
    Acta medica Scandinavica, 1984, Volume: 215, Issue:5

    Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Food; Glipizide; Glyburi

1984